# A Study to Assess the Anti-Emetic Efficacy of Ginger in Children and Adolescents Receiving Chemotherapy

> **NCT00940368** · PHASE3 · UNKNOWN · sponsor: **All India Institute of Medical Sciences** · enrollment: 60 (estimated)

## Conditions studied

- Nausea
- Vomiting

## Interventions

- **DIETARY_SUPPLEMENT:** Provision of capsules containing ginger powder or placebo

## Key facts

- **NCT ID:** NCT00940368
- **Lead sponsor:** All India Institute of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-06
- **Primary completion:** 2009-12
- **Final completion:** 2010-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2009-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00940368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00940368, "A Study to Assess the Anti-Emetic Efficacy of Ginger in Children and Adolescents Receiving Chemotherapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00940368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*